Never miss a story — sign up for PEOPLE's free daily newsletter to stay up-to-date on the best of what ... In March, the weight loss drug Wegovy was FDA-approved to prevent strokes and heart ...

Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're ...

Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...

In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help ...

which was approved for weight loss for those with obesity, or who are overweight and have a weight-related health condition, in November 2023. Although the new FDA green light doesn’t expand the ...

Each brand has its own formula for helping users achieve their weight loss goals. Their methods include remote healthcare ...

WASHINGTON — The U.S. Food and Drug Administration on Friday approved Eli Lilly's weight-loss treatment ... in other therapeutic areas. The FDA's approval is based on data from two trials ...

The Food and Drug Administration approved Eli Lilly’s ... the condition by reducing body weight, according to the FDA. The move comes as weight-loss medications have garnered immense national ...

The U.S. Food and Drug Administration (FDA) recently approved Zepbound® (tirzepatide ... OSA symptoms while also promoting significant weight loss. Zepbound is an injectable prescription ...

The U.S. Food and Drug Administration (FDA) has granted approval for Zepbound, a weight-loss medication, to treat moderate to severe obstructive sleep apnea (OSA) in individuals with obesity.